USPTO trademark

NAXEPRY

AllowedUSPTOWord markClass 5Class 16Class 44

"NAXEPRY" is a word mark owned by Amphastar Pharmaceuticals, Inc., filed at the USPTO on September 18, 2024. It has been allowed and covers classes 5, 16 and 44.

View Amphastar Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
NAXEPRY trademark as filed
As filed with the USPTO
Status
Allowed
Since May 28, 2026
Filed
September 18, 2024
Registered
Not yet
Expires
Not recorded
Application no.
98757382
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns NAXEPRY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Amphastar Pharmaceuticals, Inc.

AMPH · Rancho Cucamonga, United States

58 trademarks in the portfolioView company

Representative

Bethany J. Whelan

Dority & Manning, P.A.

Goods and services

What the mark covers

The products and services NAXEPRY is filed for, grouped by Nice class.

  • Nasal spray preparations; nasal sprays for medical purposes; nasal spray preparations for use in treating Type 1 anaphylaxis reactions; pharmaceutical formulations for use in treating Type 1 anaphylaxis reactions

  • Printed matter, namely, brochures, leaflets, and manuals in the field of pharmaceuticals, pharmaceutical research, and healthcare

  • Providing a website featuring medical information; providing information relating to diagnostic, prophylactic, and therapeutic properties of pharmaceuticals

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 2 granted
  3. Sou extension 2 filed
  4. Sou teas extension received
  5. Notice of approval of extension request e-mailed
  6. Sou extension 1 granted
  7. Sou extension 1 filed
  8. Sou teas extension received
  9. Noa e-mailed - sou required from applicant
  10. Official gazette publication confirmation e-mailed

6 earlier steps on the official record.

FAQ

About NAXEPRY

Who owns the trademark "NAXEPRY"?

The USPTO trademark "NAXEPRY" (application 98757382) is owned by Amphastar Pharmaceuticals, Inc.

What is the status of "NAXEPRY"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NAXEPRY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d29db-f625-7028-8e05-1b1d20a1f114
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d29db-f625-7028-8e05-1b1d20a1f114",
  "object": "trademark",
  "mark_text": "NAXEPRY",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "98757382",
  "filing_date": "2024-09-18",
  "nice_classes": [
    5,
    16,
    44
  ],
  "owners": [
    {
      "name": "AMPHASTAR PHARMACEUTICALS, INC.",
      "entity_id": "ent_019eb701-422d-77b5-b4f3-febfc45c6480"
    }
  ]
}